Isaac Akefe

Dr. Isaac Akefe

University of Jos, Nigeria
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2024 in The EMBO Journal
Verified
Journal Article
Open access
Isaac AkefeIsaac Akefe
Isaac Akefe
SKSaber Abd El kader
Saber Abd El kader
BMBenjamin Matthews
Benjamin Matthews
BVBharat G Venkatesh
Bharat G Venkatesh
RGRachel S Gormal
Rachel S Gormal
FMFrederic Andre Meunier
Frederic Andre Meunier
The phospholipid and free fatty acid (FFA) composition of neuronal membranes plays a crucial role in learning and memory, but the mechanisms through which neuronal activity affects the brain’s lipid landscape remain largely unexplored. The levels of saturated FFAs, particularly of myristic acid (C14:0), strongly increase during neuronal stimulation and memory acquisition, suggesting the involvement of phospholipase A1 (PLA1) activity in synaptic plasticity. Here, we show that genetic ablation of the PLA1 isoform DDHD2 in mice dramatically reduces saturated FFA responses to memory acquisition across the brain. Furthermore, DDHD2 loss also decreases memory performance in reward-based learning and spatial memory models prior to the development of neuromuscular deficits that mirror human spastic paraplegia. Via pulldown-mass spectrometry analyses, we find that DDHD2 binds to the key synaptic protein STXBP1. Using STXBP1/2 knockout neurosecretory cells and a haploinsufficient STXBP1 +/− mouse model of human early infantile encephalopathy associated with intellectual disability and motor dysfunction, we show that STXBP1 controls targeting of DDHD2 to the plasma membrane and generation of saturated FFAs in the brain. These findings suggest key roles for DDHD2 and STXBP1 in lipid metabolism and in the processes of synaptic plasticity, learning, and memory.

21 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Isaac AkefeIsaac Akefe
Isaac Akefe
JAJoseph Olusegun Ayo
Joseph Olusegun Ayo
VSVictor Olusegun Sinkalu
Victor Olusegun Sinkalu
This study investigated the effects of kaempferol and zinc gluconate on neurobehavioural and oxidative stress changes in Wistar rats exposed to noise. Thirty (30) rats were randomly divided into five groups: Groups I and II were administered with deionized water (DW); Group III, kaempferol (K); Group IV, zinc gluconate (Zn); Group V, kaempferol + zinc gluconate. Groups II, III, IV, and V were subjected to noise stress (N) induced by exposing rats to 100 dB (4 h/day) for 15 days, from day 33 to day 48 after starting the drug treatments. Neuromuscular coordination, motor coordination, motor strength, sensorimotor reflex, and learning and memory, were evaluated using standard laboratory methods. Levels of nitric oxide (NO), malondialdehyde (MDA) and activities of glutathione peroxidase (GPx), catalase and superoxide dismutase (SOD) were evaluated in the hippocampus. Exposure of rats to noise, induced significant neurobehavioural deficits and oxidative stress while the combined administration of kaempferol and zinc gluconate significantly (P < 0.05) improved open-field performance, motor coordination, motor strength, sensorimotor reflex, and learning and memory. Co-administration of kaempferol and zinc gluconate ameliorated noise-induced oxidative stress as demonstrated by the significantly increased activities of GPx, catalase, and SOD, and decreased levels of NO and MDA (P < 0.05 and P < 0.01 respectively), compared to the DW + N group. Our results suggest that oxidative stress, evidenced by increased NO and MDA concentration and decreased activities of GPx, catalase and SOD, were involved in the molecular mechanism underlying neurobehavioural impairment in Wistar rats, exposed to noise stress. Single treatment of kaempferol exerted a more potent mitigative effect than zinc gluconate, while their combination produced an improved outcome.

11 May 2020 in Recent Patents on Biotechnology
Verified
Journal Article
Closed access
PDF file
MAMatthew P. Ameh
Matthew P. Ameh
MMMamman Mohammed
Mamman Mohammed
YOYusuf P. Ofemile
Yusuf P. Ofemile
MMMagaji G. Mohammed
Magaji G. Mohammed
AGAda Gabriel
Ada Gabriel
Isaac AkefeIsaac Akefe
Isaac Akefe
Background: The World Health Organization included snakebite envenomation among Neglected Tropical Diseases in 2017. The importance of natural products from plants is enormous, given that most prescribed drugs originate from plants. Among this is Mucuna pruriens and Mimosa pudica, with many registered patents asserting their health benefits. Objective: This study investigated the in vitro neutralizing effects of Mucuna pruriens seed and Mimosa pudica root extracts on venoms of Naja nigricollis and Bitis arietans. Methods: In mice, the LD50 and phytochemical analysis of M. pruriens and M. pudica plant extracts were carried out prior to the evaluation of their haemolytic and fibrinolytic effect. Their effects on the activities of phospholipase A2 (PLA2) were also assessed. Results: At a concentration of 50 mg/ml, both plant extracts were found to neutralize the fibrinolytic activity of N. nigricollis, but 400 mg/ml was required to neutralize the fibrinolytic activity of B. arietans. In haemolytic studies, 50 mg/ml concentration of M. pruriens extract suppressed haemolysis caused by N. nigricollis venom by 70% but at the same concentration, M. pudica extract reduced haemolysis by 49.4%. M. pruriens, at 50 mg/ml concentration, only inhibited phospholipase A2 activity by 7.7% but higher concentrations up to 400mg/ml had no effect against the venom of N. nigricollis; at 200 mg/ml. M. pudica extract inhibited PLA2 activity by 23%. Conclusion: The results suggest that M. pruriens and M. pudica may be considered as promising antivenom agents for people living in a snake-bite prone environment.

1 April 2022 in Narra J
Verified
Journal Article
Open access
PDF file
GOGbeminiyi R. Otolorin
Gbeminiyi R. Otolorin
Isaac AkefeIsaac Akefe
Isaac Akefe
Olaolu Tosin OlufemiOlaolu Tosin Olufemi
Olaolu Tosin Olufemi
DEDaniel O. Esonu
Daniel O. Esonu
HDHassana I. Dunka
Hassana I. Dunka
PMPhilip P. Mshelbwala
Philip P. Mshelbwala
Many researchers worldwide have focused on the health impact of the coronavirus disease 2019 (COVID-19) pandemic without paying much emphasis to the environmental impacts associated with the pandemic. Evidence suggests that prior to the pandemic there was an alarming increase in environmental pollution due to rising industrialization, in particular in urban areas. Following the COVID-19 pandemic, satellite data over Asia and Europe showed a substantial decrease in air pollution, in particular nitrogen dioxide. However, the increase in industrial and household wastes may pose a significant challenge to environmental management. The improper management of these wastes poses an unforeseen “knock-on” effect on human health and the environment. It is imperative to establish an effective and safe procedure, for handling and disposing of the consequential wastes accumulating during the pandemic. The review aims to highlight both the beneficial and detrimental effects of COVID-19 pandemic on the natural environment and to discuss the possible strategies to improve the quality of the global environment during the period of the pandemic and beyond.

13 July 2020 in Comparative Clinical Pathology
Verified
Journal Article
Closed access
PDF file
ILIbrahim Yusuf Lamidi
Ibrahim Yusuf Lamidi
MHMikail Garba Hudu
Mikail Garba Hudu
Isaac AkefeIsaac Akefe
Isaac Akefe
SASani Adamu
Sani Adamu
SSSabo Isa Salihu
Sabo Isa Salihu

3 June 2025 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
HFHasti Fadakar
Hasti Fadakar
PRPriyanka Rudra
Priyanka Rudra
AAApil Adhikari
Apil Adhikari
GPGalhenage Kethmi Perera
Galhenage Kethmi Perera
VSVichari Sirimanne
Vichari Sirimanne
Isaac AkefeIsaac Akefe
Isaac Akefe
Epilepsy is a neurological disorder affecting approximately 50 million people globally and is characterised by recurrent, unprovoked seizures resulting from abnormal, excessive synchronised firing of neurons. Developing new therapeutic targets and biomarkers is key to improving the diagnosis, treatment, and management. This scoping review examines the current literature on the preclinical and clinical applications of dietary interventions that target the neurolipidome in epilepsy. Specifically, it investigates the role of lipids in the underlying pathogenesis of epilepsy. A comprehensive search of databases was conducted to identify peer-reviewed articles published in the past ten years. Original research articles focusing on both adult and paediatric epilepsy and disrupted lipid metabolism were included, resulting in a total of 101 papers. Our review identified several key lipids implicated in the pathogenesis of epilepsy, including sphingolipids, free fatty acids, endocannabinoids, cholesterol, triglycerides, and phospholipids, and also explores the complex interactions between these lipids and their roles in the disease process. Furthermore, our study highlighted that the Ketogenic Diet (KD) and Modified Atkins Diet (MAD) have proven effective adjunctive or alternative treatments in paediatric and adult populations, improving patient quality of life and reducing seizure frequency. Additionally, treatment with lipid-based supplements, such as eicosapentaenoic acid, docosahexaenoic acid, fish oil, and cannabidiol, has been associated with a reduction in seizure rates in patients with drug-resistant epilepsy. In summary, findings from this study indicate that KD and MAD lipid-based supplements are effective for managing epilepsy in paediatrics, adults, and animal models. However, further research is necessary to elucidate the pathophysiological mechanisms underlying the role of lipids in the development and progression of epilepsy.